Associated Papers
High prevalence and emerging positive association of kelch13 R622I and HRP2-based RDT negativity in Plasmodium falciparum in northern Ethiopia.
Zeleke AJ et al.
Plos Pathogens, 2025
41379859 (PubMed )
Supplement: ppat.1013771.s013.xlsx › Sheet1
Very Low Prevalence of Validated kelch13 Mutations and Absence of Histidine-Rich Protein 2/3 Double Gene Deletions in South African Malaria-Eliminating Districts (2022-2024).
Raman J et al.
The American Journal of Tropical Medicine and Hygiene, 2025
Very low prevalence of validated kelch13 mutations and absence of hrp2/3 double gene deletions in South African malaria-eliminating districts (2022-2024).
Raman J et al.
Medrxiv : the Preprint Server for Health Sciences, 2025
Molecular detection of drug-resistant Plasmodium falciparum mutants in Assam.
Barman L et al.
The Indian Journal of Medical Research, 2023
Absence of Association between Methylene Blue Reduced Susceptibility and Polymorphisms in 12 Genes Involved in Antimalarial Drug Resistance in African Plasmodium falciparum.
Gendrot M et al.
Pharmaceuticals (basel, Switzerland), 2021
Molecular surveillance of pfcrt, pfmdr1 and pfk13-propeller mutations in Plasmodium falciparum isolates imported from Africa to China.
Huang F et al.
Malaria Journal, 2021
Limited ability of Plasmodium falciparum pfcrt, pfmdr1, and pfnhe1 polymorphisms to predict quinine in vitro sensitivity or clinical effectiveness in Uganda.
Baliraine FN et al.
Antimicrobial Agents and Chemotherapy, 2011
Select a paper to view details